Giganti Francesco, Ambrosi Alessandro, Chiari Damiano, Orsenigo Elena, Esposito Antonio, Mazza Elena, Albarello Luca, Staudacher Carlo, Del Maschio Alessandro, De Cobelli Francesco
Department of Radiology and Experimental Imaging Center, San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.
Chin J Cancer Res. 2017 Apr;29(2):118-126. doi: 10.21147/j.issn.1000-9604.2017.02.04.
OBJECTIVE: To investigate the role of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) when applied to the 7th TNM classification in the staging and prognosis of gastric cancer (GC). METHODS: Between October 2009 and May 2014, a total of 89 patients with non-metastatic, biopsy proven GC underwent 1.5T DW-MRI, and then treated with radical surgery. Tumor ADC was measured retrospectively and compared with final histology following the 7th TNM staging (local invasion, nodal involvement and according to the different groups - stage I, II and III). Kaplan-Meier curves were also generated. The follow-up period is updated to May 2016. RESULTS: Median follow-up period was 33 months and 45/89 (51%) deaths from GC were observed. ADC was significantly different both for local invasion and nodal involvement (P<0.001). Considering final histology as the reference standard, a preoperative ADC cut-off of 1.80×10 mm/s could distinguish between stages I and II and an ADC value of ≤1.36×10 mm/s was associated with stage III (P<0.001). Kaplan-Meier curves demonstrated that the survival rates for the three prognostic groups were significantly different according to final histology and ADC cut-offs (P<0.001). CONCLUSIONS: ADC is different according to local invasion, nodal involvement and the 7th TNM stage groups for GC, representing a potential, additional prognostic biomarker. The addition of DW-MRI could aid in the staging and risk stratification of GC.
目的:探讨扩散加权磁共振成像(DW-MRI)中的表观扩散系数(ADC)应用于胃癌(GC)第七版TNM分期时在其分期及预后评估中的作用。 方法:2009年10月至2014年5月期间,共89例经活检证实为非转移性GC的患者接受了1.5T DW-MRI检查,随后接受根治性手术。回顾性测量肿瘤ADC值,并与第七版TNM分期(局部侵犯、淋巴结受累情况以及根据不同分组——I期、II期和III期)后的最终组织学结果进行比较。同时绘制Kaplan-Meier曲线。随访期更新至2016年5月。 结果:中位随访期为33个月,观察到45/89(51%)例患者死于GC。局部侵犯和淋巴结受累情况下的ADC值均存在显著差异(P<0.001)。以最终组织学结果作为参考标准,术前ADC临界值为1.80×10⁻³mm²/s可区分I期和II期,ADC值≤1.36×10⁻³mm²/s与III期相关(P<0.001)。Kaplan-Meier曲线表明,根据最终组织学结果和ADC临界值,三个预后组的生存率存在显著差异(P<0.001)。 结论:GC的ADC值因局部侵犯、淋巴结受累情况及第七版TNM分期组不同而有所差异,代表一种潜在的额外预后生物标志物。增加DW-MRI检查有助于GC的分期及风险分层。
Cochrane Database Syst Rev. 2015-2-6
Insights Imaging. 2022-3-22
Chin J Cancer Res. 2021-4-30
Diagn Interv Radiol. 2020-5
J Gastroenterol Hepatol. 2016-9
Pathol Int. 2015-8
Cochrane Database Syst Rev. 2015-2-6
Radiology. 2015-3-27